サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1181069

脳深部刺激（DBS）装置の世界市場：市場規模、シェア、動向分析、機会、予測：タイプ別、流通チャネル別、エンドユーザー別、機能性別、用途別、地域別（2018年～2028年）

Deep Brain Stimulation Devices Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2018-2028, Segmented By Type ; Distribution Channel ; End User ; Functionality ; Application ; Region
出版日: | 発行: Blueweave Consulting | ページ情報: 英文 245 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
脳深部刺激（DBS）装置の世界市場：市場規模、シェア、動向分析、機会、予測：タイプ別、流通チャネル別、エンドユーザー別、機能性別、用途別、地域別（2018年～2028年）
出版日: 2022年12月16日
発行: Blueweave Consulting
ページ情報: 英文 245 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の脳深部刺激（DBS）装置市場の収益は、2021年に11億米ドルとなり、2028年末には約20億米ドルに達し、2022年～2028年の予測期間中にCAGRで9.2％の成長が予測されています。高齢者人口の増加と技術の進歩により、市場は高いCAGRで成長すると予測されています。

パーキンソン病（PD）、ジストニア、多発性硬化症に関連する不随意運動患者の増加により、市場は急成長しています。また、患者の予後改善に伴う低侵襲手術の需要増加は、市場の重要な促進要因となっています。

当レポートでは、世界の脳深部刺激（DBS）装置市場について調査し、市場変数の洞察、タイプ・流通チャネル・エンドユーザー・機能性・用途別の市場分析、競合情勢、企業プロファイル等に関する情報を提供しています。

目次

第1章 調査の枠組み

第2章 エグゼクティブサマリー

第3章 世界の脳深部刺激（DBS）装置の市場変数の洞察

  • 業界バリューチェーン分析
  • DROC分析
    • 成長促進要因
      • 世界の神経疾患における有病率の上昇
      • 研究・開発（R&D）の増加
      • 先進国における低侵襲手術の需要増加
    • 抑制要因
      • 脳深部刺激（DBS）療法の高額な費用
    • 機会
      • より高い有効性、より多くの患者の受け入れ
    • 課題
      • IPGのリスクは、脳深部刺激（DBS）装置の受け入れに影響
  • 技術の進歩/最近の開発
  • 規制の枠組み
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入者の脅威
    • 代替品の脅威
    • 競合の激しさ

第4章 世界の脳深部刺激（DBS）装置の市場概要

  • 市場規模・予測：金額別（2020年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
      • 開ループDBS
      • 閉ループDBS
    • 流通チャネル別
      • オンライン
      • オフライン
    • エンドユーザー別
      • 病院
      • 専門神経科クリニック
      • 研究センター
      • その他
    • 機能性別
      • 片側デュアルチャネル脳深部刺激（DBS）装置
      • 両面脳深部刺激（DBS）装置
    • 用途別
      • パーキンソン病
      • てんかん
      • 本態性振戦
      • ジストニア
      • 強迫性障害（OCD）
      • その他
    • 地域別
      • 北米
      • 欧州
      • アジア太平洋
      • ラテンアメリカ
      • 中東・アフリカ

第5章 北米の脳深部刺激（DBS）装置市場

  • 市場規模・予測：金額別（2018年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 機能性別
    • 用途別
    • 国別
      • 米国
      • カナダ

第6章 欧州の脳深部刺激（DBS）装置市場

  • 市場規模・予測：金額別（2018年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 機能性別
    • 用途別
    • 国別
      • ドイツ
      • 英国
      • イタリア
      • フランス
      • スペイン
      • オランダ
      • ベルギー
      • 北欧諸国
      • その他の欧州

第7章 アジア太平洋の脳深部刺激（DBS）装置市場

  • 市場規模・予測：金額別（2018年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 機能性別
    • 用途別
    • 国別
      • 中国
      • インド
      • 日本
      • 韓国
      • オーストラリア
      • インドネシア
      • マレーシア
      • フィリピン
      • シンガポール
      • その他のアジア太平洋

第8章 ラテンアメリカの脳深部刺激（DBS）装置市場

  • 市場規模・予測：金額別（2018年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 機能性別
    • 用途別
    • 国別
      • ブラジル
      • メキシコ
      • アルゼンチン
      • チリ
      • ペルー
      • その他のラテンアメリカ

第9章 中東・アフリカの脳深部刺激（DBS）装置市場

  • 市場規模・予測：金額別（2018年～2028年）
    • 金額別（100万米ドル）
  • 市場シェア・予測
    • タイプ別
    • 流通チャネル別
    • エンドユーザー別
    • 機能性別
    • 用途別
    • 国別
      • サウジアラビア
      • アラブ首長国連邦
      • 南アフリカ
      • カタール
      • トルコ
      • ナイジェリア
      • エジプト
      • アルジェリア
      • ケニア
      • モロッコ
      • その他の中東・アフリカ

第10章 競合情勢

  • 主要企業とその製品リスト
  • 市場シェア分析、2021年
  • 競合ベンチマーキング：操作パラメータ別
  • 主要な戦略的展開（合併、買収、パートナーシップなど）

第11章 世界の脳深部刺激（DBS）装置市場に対するCOVID-19の影響

第12章 企業プロファイル

  • Abbott
  • Aleva Neurotherapeutics
  • Boston Scientific Corporation
  • LivaNova PLC
  • Medtronic
  • NeuroSigma, Inc.
  • NeuroPace, Inc.
  • Nexstim

第13章 主要な戦略的推奨事項

第14章 調査手法

目次
Product Code: BWC22604

Global Deep Brain Stimulation Devices Market to Reach USD 2.0 Billion by 2028

Global deep brain stimulation devices market is forecasted to grow at a higher CAGR due to the rise in geriatric population and technological advancements. The rapid relief from symptoms provided by deep brain stimulation makes it the treatment of choice as it reduces the dose and frequency of drugs consumed on a daily basis via the oral route, leading to rise in patient satisfaction and trust in the medical intervention.

A recent study conducted by the strategic consulting and market research firm, BlueWeave Consulting, revealed that the global deep brain stimulation was worth USD 1.1 billion in the year 2021. The market is projected to grow at a CAGR of 9.2% from 2022-2028 (forecast period), earning revenues of around USD 2.0 billion by the end of 2028. The market is booming owing to the rise in individuals with Parkinson's disease (PD), dystonia, and multiple sclerosis-related involuntary movements. Additionally, the increased demand for minimally invasive procedures as a result of better patient outcomes is a significant market driver. Furthermore, the deep brain stimulation device market is supported by the advent of telehealth consultations and e-health apps to frequently monitor PD patients during the COVID-19 pandemic.

Higher Efficacy, Greater Patient Acceptance Boosting the Global Deep Brain Stimulation Market

Due to the increasingly aging population, altered lifestyles, rising rates of obesity, and high blood pressure, among other things, there are now significantly more neurological illnesses, such as Parkinson's disease. Over 50 million individuals have epilepsy, according to a World Health Organization (WHO) report released in September 2021. Alzheimer's disease is responsible for between 60 and 70% of dementia cases. An estimated 35.6 million people are afflicted with dementia, and 7.7 million new cases are identified each year.

Additionally, the market for deep brain stimulation devices is expected to expand substantially over the course of the forecast period as a result of the rise in patients with these conditions and the rising usage of these devices, which facilitate recovery. For instance, deep brain stimulation devices were reportedly utilized on over 160,000 patients globally in 2019 for a variety of neurological and non-neurological diseases, with the number rising year after year, according to the National Center for Biotechnology Information (NCBI).

Restraint

Risk of IPG (Implantable Pulse Generator Associated Infection) Affects Acceptance of Deep Brain Stimulation Devices

Throughout the assessment period, the global market for deep brain stimulation devices is anticipated to grow at a positive year-on-year rate. However, there are a few variables that are predicted to work against the market's growth. The hazards associated with deep brain stimulation device operations are one of the major reasons impeding the market's growth.

For example, in deep brain systems, the implanted pulse generator (IPG) is the main power source and programmable element. However, the danger of infection from IPG is significant enough and is predicted to limit the use of deep brain stimulation devices for Parkinson's disease and other neurological conditions. As a result, healthcare organizations should raise knowledge regarding antibiotic impregnation and co-administration, as well as other surgical considerations during IPG implantation, such as using tack-up sutures and smaller profile devices.

Global Deep Brain Stimulation Devices market - By Functionality

Dual-channel deep brain stimulators and single-channel deep brain stimulators are the two product categories that make up the market. Throughout the forecast period, the dual channel deep brain stimulator segment is anticipated to maintain a significant share. This might be a result of deep brain stimulator technology continuing to progress. Deep brain stimulators with dual channels have more sophisticated technology than those with single channels. One-sided dual-channel deep brain stimulators, which deliver electrical pulse stimulation through two DEEP BRAIN STIMULATION leads, were created to simplify the procedure for bilateral treatment and increase patient comfort. So, over the projection period, growing developments in DEEP BRAIN STIMULATION stimulators will significantly boost the market growth.

Global Deep Brain Stimulation Devices Market - By Application

Based on application, the market has been further divided into Parkinson's disease, epilepsy, essential tremor, dystonia, and obsessive-compulsive disorder. The Parkinson's disease segment dominated the market for deep brain stimulation devices in 2021, accounting for over 60% of the revenue share owing to the high prevalence of Parkinson's disease worldwide. The Parkinson's Foundation estimates that 60,000 Americans are given a Parkinson's disease diagnosis each year. This is expected to encourage segment expansion during the next years.

Regional Insights

The global deep brain stimulation devices market is currently dominated by North America in terms of revenue. According to a National Institute of Neurological Disorders and Stroke (NINDS) report, North America dominated the market due to the presence of cutting-edge and innovative healthcare infrastructure in this region, the high prevalence of neurological disorders like Parkinson's disease and epilepsy, and government initiatives that favor patients with neurological conditions. Moreover, significant market expansion potentially occurs in the Asia Pacific region. Increasing research in the neurological area, an increase in patients with neurodegenerative diseases, and enhanced clinical procedures are all driving this region's market growth. However, there is evidence of rapid growth in Asian countries like Japan and South Korea, which can foster market expansion due to the rise in patients and the emergence of institutions focused on neurological research, among other things.

Impact of COVID-19 on Global Deep Brain Stimulation Market

The unprecedented global public health emergency known as COVID-19 has had an impact on almost every business, and the long-term effects are anticipated to have an impact on industry growth throughout the course of the projected period. It is important to understand that the deep brain stimulation devices market has been negatively impacted as a result of the global restrictions brought on by the pandemic in order to ensure the inclusion of underlying COVID-19 concerns and potential future directions. With prohibitions lifted in most countries and a larger proportion of the population immunized, it is predicted that the deep brain stimulation devices market will experience positive growth during the forecast period.

Competitive Landscape

The leading companies in the market include Abbott, Aleva Neurotherapeutics, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroSigma, Inc., NeuroPace, Inc., Nexstim, and Other Prominent Players. Major market competitors use various techniques, including mergers and acquisitions, innovative therapies, and others, to stay competitive and gain an advantage over rivals.

The global deep brain stimulation devices market is consolidated with the presence of several manufacturing companies globally. The market leaders retain their supremacy by spending on research and development, incorporating cutting-edge technology into their goods, and releasing upgraded items for customers. Various tactics, including strategic alliances, agreements, mergers, and partnerships, are used.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of the global deep brain stimulation market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the global deep brain stimulation devices market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

  • 1.1. Research Objective
  • 1.2. Product Overview
  • 1.3. Market Segmentation

2. Executive Summary

3. Global Deep Brain Stimulation Devices Market Variable Insights

  • 3.1. Industry Value Chain Analysis
  • 3.2. DROC Analysis
    • 3.2.1. Growth Drivers
      • 3.2.1.1. Global Rise in Prevalence of Neurological Disorders
      • 3.2.1.2. Rising Research & Development (R&D)
      • 3.2.1.3. Increasing Demand for Minimally Invasive Surgery in Developed Countries
    • 3.2.2. Restraints
      • 3.2.2.1. High Cost of Deep Brain Stimulation Therapy
    • 3.2.3. Opportunities
      • 3.2.3.1. Higher Efficacy, Greater Patient Acceptance
    • 3.2.4. Challenges
      • 3.2.4.1. Risk of IPG (Implantable Pulse Generator Associated Infection) Affects Acceptance of Deep Brain Stimulation Devices
  • 3.3. Technological Advancements/Recent Developments
  • 3.4. Regulatory Framework
  • 3.5. Porter's Five Forces Analysis
    • 3.5.1. Bargaining Power of Suppliers
    • 3.5.2. Bargaining Power of Buyers
    • 3.5.3. Threat of New Entrants
    • 3.5.4. Threat of Substitutes
    • 3.5.5. Intensity of Rivalry

4. Global Deep Brain Stimulation Devices Market Overview

  • 4.1. Market Size & Forecast by Value, 2020-2028
    • 4.1.1. By Value (USD Million)
  • 4.2. Market Share & Forecast
    • 4.2.1. By Type
      • 4.2.1.1. Open Loop DBS
      • 4.2.1.2. Closed Loop DBS
    • 4.2.2. By Distributional Channel
      • 4.2.2.1. Online
      • 4.2.2.2. Offline
    • 4.2.3. By End User
      • 4.2.3.1. Hospitals
      • 4.2.3.2. Specialized Neurology Clinics
      • 4.2.3.3. Research Centers
      • 4.2.3.4. Others
    • 4.2.4. By Functionality
      • 4.2.4.1. One-sided dual channel deep brain stimulator
      • 4.2.4.2. Two-sided deep brain stimulators
    • 4.2.5. By Application
      • 4.2.5.1. Parkinson's Disease
      • 4.2.5.2. Epilepsy
      • 4.2.5.3. Essential Tremor
      • 4.2.5.4. Dystonia
      • 4.2.5.5. Obsessive Compulsive Disorder (OCD)
      • 4.2.5.6. Others
    • 4.2.6. By Region
      • 4.2.6.1. North America
      • 4.2.6.2. Europe
      • 4.2.6.3. Asia Pacific
      • 4.2.6.4. Latin America
      • 4.2.6.5. Middle East and Africa

5. North America Deep Brain Stimulation Devices Market

  • 5.1. Market Size & Forecast by Value, 2018-2028
    • 5.1.1. By Value (USD Million)
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type
    • 5.2.2. By Distribution Channel
    • 5.2.3. By End User
    • 5.2.4. By Functionality
    • 5.2.5. By Application
    • 5.2.6. By Country
      • 5.2.6.1. United States
      • 5.2.6.1.1. By Type
      • 5.2.6.1.2. By Distribution Channel
      • 5.2.6.1.3. By End User
      • 5.2.6.1.4. By Functionality
      • 5.2.6.1.5. By Application
      • 5.2.6.2. Canada
      • 5.2.6.2.1. By Type
      • 5.2.6.2.2. By Distribution Channel
      • 5.2.6.2.3. By End User
      • 5.2.6.2.4. By Functionality
      • 5.2.6.2.5. By Application

6. Europe Deep Brain Stimulation Devices Market

  • 6.1. Market Size & Forecast by Value, 2018-2028
    • 6.1.1. By Value (USD Million)
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By End User
    • 6.2.4. By Functionality
    • 6.2.5. By Application
    • 6.2.6. By Country
      • 6.2.6.1. Germany
      • 6.2.6.1.1. By Type
      • 6.2.6.1.2. By Distribution Channel
      • 6.2.6.1.3. By End User
      • 6.2.6.1.4. By Functionality
      • 6.2.6.1.5. By Application
      • 6.2.6.2. United Kingdom
      • 6.2.6.2.1. By Type
      • 6.2.6.2.2. By Distribution Channel
      • 6.2.6.2.3. By End User
      • 6.2.6.2.4. By Functionality
      • 6.2.6.2.5. By Application
      • 6.2.6.3. Italy
      • 6.2.6.3.1. By Type
      • 6.2.6.3.2. By Distribution Channel
      • 6.2.6.3.3. By End User
      • 6.2.6.3.4. By Functionality
      • 6.2.6.3.5. By Application
      • 6.2.6.4. France
      • 6.2.6.4.1. By Type
      • 6.2.6.4.2. By Distribution Channel
      • 6.2.6.4.3. By End User
      • 6.2.6.4.4. By Functionality
      • 6.2.6.4.5. By Application
      • 6.2.6.5. Spain
      • 6.2.6.5.1. By Type
      • 6.2.6.5.2. By Distribution Channel
      • 6.2.6.5.3. By End User
      • 6.2.6.5.4. By Functionality
      • 6.2.6.5.5. By Application
      • 6.2.6.6. The Netherlands
      • 6.2.6.6.1. By Type
      • 6.2.6.6.2. By Distribution Channel
      • 6.2.6.6.3. By End User
      • 6.2.6.6.4. By Functionality
      • 6.2.6.6.5. By Application
      • 6.2.6.7. Belgium
      • 6.2.6.7.1. By Type
      • 6.2.6.7.2. By Distribution Channel
      • 6.2.6.7.3. By End User
      • 6.2.6.7.4. By Functionality
      • 6.2.6.7.5. By Application
      • 6.2.6.8. NORDIC Countries
      • 6.2.6.8.1. By Type
      • 6.2.6.8.2. By Distribution Channel
      • 6.2.6.8.3. By End User
      • 6.2.6.8.4. By Functionality
      • 6.2.6.8.5. By Application
      • 6.2.6.9. Rest of Europe
      • 6.2.6.9.1. By Type
      • 6.2.6.9.2. By Distribution Channel
      • 6.2.6.9.3. By End User
      • 6.2.6.9.4. By Functionality
      • 6.2.6.9.5. By Application

7. Asia Pacific Deep Brain Stimulation Devices Market

  • 7.1. Market Size & Forecast by Value, 2018-2028
    • 7.1.1. By Value (USD Million)
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Functionality
    • 7.2.5. By Application
    • 7.2.6. By Country
      • 7.2.6.1. China
      • 7.2.6.1.1. By Type
      • 7.2.6.1.2. By Distribution Channel
      • 7.2.6.1.3. By End User
      • 7.2.6.1.4. By Functionality
      • 7.2.6.1.5. By Application
      • 7.2.6.2. India
      • 7.2.6.2.1. By Type
      • 7.2.6.2.2. By Distribution Channel
      • 7.2.6.2.3. By End User
      • 7.2.6.2.4. By Functionality
      • 7.2.6.2.5. By Application
      • 7.2.6.3. Japan
      • 7.2.6.3.1. By Type
      • 7.2.6.3.2. By Distribution Channel
      • 7.2.6.3.3. By End User
      • 7.2.6.3.4. By Functionality
      • 7.2.6.3.5. By Application
      • 7.2.6.4. South Korea
      • 7.2.6.4.1. By Type
      • 7.2.6.4.2. By Distribution Channel
      • 7.2.6.4.3. By End User
      • 7.2.6.4.4. By Functionality
      • 7.2.6.4.5. By Application
      • 7.2.6.5. Australia
      • 7.2.6.5.1. By Type
      • 7.2.6.5.2. By Distribution Channel
      • 7.2.6.5.3. By End User
      • 7.2.6.5.4. By Functionality
      • 7.2.6.5.5. By Application
      • 7.2.6.6. Indonesia
      • 7.2.6.6.1. By Type
      • 7.2.6.6.2. By Distribution Channel
      • 7.2.6.6.3. By End User
      • 7.2.6.6.4. By Functionality
      • 7.2.6.6.5. By Application
      • 7.2.6.7. Malaysia
      • 7.2.6.7.1. By Type
      • 7.2.6.7.2. By Distribution Channel
      • 7.2.6.7.3. By End User
      • 7.2.6.7.4. By Functionality
      • 7.2.6.7.5. By Application
      • 7.2.6.8. Philippines
      • 7.2.6.8.1. By Type
      • 7.2.6.8.2. By Distribution Channel
      • 7.2.6.8.3. By End User
      • 7.2.6.8.4. By Functionality
      • 7.2.6.8.5. By Application
      • 7.2.6.9. Singapore
      • 7.2.6.9.1. By Type
      • 7.2.6.9.2. By Distribution Channel
      • 7.2.6.9.3. By End User
      • 7.2.6.9.4. By Functionality
      • 7.2.6.9.5. By Application
      • 7.2.6.10. Rest of Asia Pacific
      • 7.2.6.10.1. By Type
      • 7.2.6.10.2. By Distribution Channel
      • 7.2.6.10.3. By End User
      • 7.2.6.10.4. By Functionality
      • 7.2.6.10.5. By Application

8. Latin America Deep Brain Stimulation Devices Market

  • 8.1. Market Size & Forecast by Value, 2018-2028
    • 8.1.1. By Value (USD Million)
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Functionality
    • 8.2.5. By Application
    • 8.2.6. By Country
      • 8.2.6.1. Brazil
      • 8.2.6.1.1. By Type
      • 8.2.6.1.2. By Distribution Channel
      • 8.2.6.1.3. By End User
      • 8.2.6.1.4. By Functionality
      • 8.2.6.1.5. By Application
      • 8.2.6.2. Mexico
      • 8.2.6.2.1. By Type
      • 8.2.6.2.2. By Distribution Channel
      • 8.2.6.2.3. By End User
      • 8.2.6.2.4. By Functionality
      • 8.2.6.2.5. By Application
      • 8.2.6.3. Argentina
      • 8.2.6.3.1. By Type
      • 8.2.6.3.2. By Distribution Channel
      • 8.2.6.3.3. By End User
      • 8.2.6.3.4. By Functionality
      • 8.2.6.3.5. By Application
      • 8.2.6.4. Chile
      • 8.2.6.4.1. By Type
      • 8.2.6.4.2. By Distribution Channel
      • 8.2.6.4.3. By End User
      • 8.2.6.4.4. By Functionality
      • 8.2.6.4.5. By Application
      • 8.2.6.5. Peru
      • 8.2.6.5.1. By Type
      • 8.2.6.5.2. By Distribution Channel
      • 8.2.6.5.3. By End User
      • 8.2.6.5.4. By Functionality
      • 8.2.6.5.5. By Application
      • 8.2.6.6. Rest of Latin America

9. Middle East and Africa Deep Brain Stimulation Devices Market

  • 9.1. Market Size & Forecast by Value, 2018-2028
    • 9.1.1. By Value (USD Million)
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Functionality
    • 9.2.5. By Application
    • 9.2.6. By Country
      • 9.2.6.1. Saudi Arabia
      • 9.2.6.1.1. By Type
      • 9.2.6.1.2. By Distribution Channel
      • 9.2.6.1.3. By End User
      • 9.2.6.1.4. By Functionality
      • 9.2.6.1.5. By Application
      • 9.2.6.2. UAE
      • 9.2.6.2.1. By Type
      • 9.2.6.2.2. By Distribution Channel
      • 9.2.6.2.3. By End User
      • 9.2.6.2.4. By Functionality
      • 9.2.6.2.5. By Application
      • 9.2.6.3. South Africa
      • 9.2.6.3.1. By Type
      • 9.2.6.3.2. By Distribution Channel
      • 9.2.6.3.3. By End User
      • 9.2.6.3.4. By Functionality
      • 9.2.6.3.5. By Application
      • 9.2.6.4. Qatar
      • 9.2.6.4.1. By Type
      • 9.2.6.4.2. By Distribution Channel
      • 9.2.6.4.3. By End User
      • 9.2.6.4.4. By Functionality
      • 9.2.6.4.5. By Application
      • 9.2.6.5. Turkey
      • 9.2.6.5.1. By Type
      • 9.2.6.5.2. By Distribution Channel
      • 9.2.6.5.3. By End User
      • 9.2.6.5.4. By Functionality
      • 9.2.6.5.5. By Application
      • 9.2.6.6. Nigeria
      • 9.2.6.6.1. By Type
      • 9.2.6.6.2. By Distribution Channel
      • 9.2.6.6.3. By End User
      • 9.2.6.6.4. By Functionality
      • 9.2.6.6.5. By Application
      • 9.2.6.7. Egypt
      • 9.2.6.7.1. By Type
      • 9.2.6.7.2. By Distribution Channel
      • 9.2.6.7.3. By End User
      • 9.2.6.7.4. By Functionality
      • 9.2.6.7.5. By Application
      • 9.2.6.8. Algeria
      • 9.2.6.8.1. By Type
      • 9.2.6.8.2. By Distribution Channel
      • 9.2.6.8.3. By End User
      • 9.2.6.8.4. By Functionality
      • 9.2.6.8.5. By Application
      • 9.2.6.9. Kenya
      • 9.2.6.9.1. By Type
      • 9.2.6.9.2. By Distribution Channel
      • 9.2.6.9.3. By End User
      • 9.2.6.9.4. By Functionality
      • 9.2.6.9.5. By Application
      • 9.2.6.10. Morocco
      • 9.2.6.10.1. By Type
      • 9.2.6.10.2. By Distribution Channel
      • 9.2.6.10.3. By End User
      • 9.2.6.10.4. By Functionality
      • 9.2.6.10.5. By Application
      • 9.2.6.11. Rest of Middle East and Africa
      • 9.2.6.11.1. By Type
      • 9.2.6.11.2. By Distribution Channel
      • 9.2.6.11.3. By End User
      • 9.2.6.11.4. By Functionality
      • 9.2.6.11.5. By Application

10. Competitive Landscape

  • 10.1. List of Key Players and Their offerings
  • 10.2. Market Share Analysis, 2021
  • 10.3. Competitive Benchmarking, By Operating Parameters
  • 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Deep Brain Stimulation Devices Market

12. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, SWOT, and Strategic Outlook) **

  • 13.1. Abbott
  • 13.2. Aleva Neurotherapeutics
  • 13.3. Boston Scientific Corporation
  • 13.4. LivaNova PLC
  • 13.5. Medtronic
  • 13.6. NeuroSigma, Inc.
  • 13.7. NeuroPace, Inc.
  • 13.8. Nexstim
  • 13.9. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

  • 14.1. Qualitative Research

Primary & Secondary Research

  • 14.2. Quantitative Research
  • 14.3. Market Breakdown & Data Triangulation
    • 14.3.1. Secondary Research
    • 14.3.2. Primary Research
  • 14.4. Breakdown of Primary Research Respondents, By Region
  • 14.5. Assumptions & Limitations